A tool company that runs its own bench.
T&L began in 2011 as a reagent developer for cell and gene therapy. The platform came later: once you own the assay data, the design models and the manufacturing, the same loop can produce tools for any workflow — not just the one you started with.
Fifteen years, one loop.
We started in 2011 with a narrow question: what would it take for a CGT developer to buy a critical reagent from a supplier who understood the regulatory path, not just the catalogue?
The answer was four tool families — magnetic beads, monoclonal antibodies, recombinant proteins and serum-free media — developed in-house, manufactured under ISO 13485 and ISO 9001, and documented to the level a sponsor needs when the file goes to a regulator.
The next step is the part that makes it a platform rather than a catalogue: instrumenting the data behind those tools, letting models propose what to build next, and qualifying outside capacity so throughput is not capped by one building.
Three in-house development platforms — magnetic beads, recombinant protein expression and serum-free media — under a single quality system.
Three development platforms, one quality system.
Bead development, eukaryotic and prokaryotic protein expression, and serum-free medium formulation sit under the same quality system — which is why a change in one does not force a re-qualification of the others.
Cell-separation magnetic beads
Particle synthesis, antibody coupling, blocking and release chemistry, from 50 nm nanobeads to 4.5 µm activation beads.
Protein expression
E. coli, HEK293 and CHO expression with process development, purification and characterisation under one roof.
Serum-free media
Chemically defined, animal-origin-free formulations for NK, MSC, PSC and HEK293 suspension culture.
Fifteen years, five turns.
Best Raw Material Supplier, 2024.
Awarded at the 5th CGT Asia 2024 cell and gene therapy innovation summit in Shanghai — voted by the people who actually run these processes.
We hire people who like the unglamorous part.
Bead chemistry, purification development, QA documentation, regulatory affairs. If you have done the bench work and also care whether the batch record is right, we should talk.
Send an introduction